Clinical Trial Update: Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy [Phase 2, Phase 3]

View source ↗

Summary

A study evaluating the efficacy and safety of BHV-7000 in adults with refractory focal onset epilepsy is ongoing (Phase 2/3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Drugs mentioned

• BHV-7000

Snippet

Sponsor: Biohaven Therapeutics Ltd. | Conditions: Focal Epilepsy | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING